Soft Tissue Sarcoma of Extremities: Descriptive Epidemiological Analysis According to National Population-based Study
- PMID: 35291240
- PMCID: PMC8889428
- DOI: 10.22038/ABJS.2021.53750.2676
Soft Tissue Sarcoma of Extremities: Descriptive Epidemiological Analysis According to National Population-based Study
Abstract
Background: Soft-Tissue Sarcoma (STS) is a heterogeneous group of neoplasms of mesenchymal origin, occurring in connective tissues. According to previously conducted studies, STS accounts for approximately 1% and 7-%15% of adult and pediatric malignancies, respectively. Almost 50%-60% of sarcomas arise from extremities and usually present as a large painless or rarely painful soft-tissue mass. The present study aimed to describe the epidemiology of soft-tissue sarcomas, especially in the Iranian population.
Methods: This epidemiological study of limb soft-tissue sarcoma was conducted based on Iran National Cancer Registry data (INCR) between 2009 and 2014. Patients with soft-tissue sarcoma confirmed by histopathological studies were included, and data were classified based on the International Classification of Diseases for Oncology (first revision-third edition [ICD-O-3]) and analyzed. Descriptive analysis was performed to extract age-standardized and age-specific incidence rates.
Results: A total of 2, 593 patients (1,476 males and 1,117 females) were enrolled and assessed in the present study. The age-standardized incidence rate(ASIR) of total soft tissue sarcomas was 6.34 per million person-years. In addition, the highest and lowest ASIR scores stratified by age were observed in patients aged above 65 and under 0 with the value of 19.61 (95% CI:17.91-21.30) and 1.91 (95% CI 1.69, 2.13) per million, respectively. Limb soft tissue sarcomas stratified by gender were dominant in males, and it was statistically significant (P<0.05). The most common extremity soft tissue sarcomas subtypes were mesenchymal tumor (12.26%), spindle cell sarcoma (12.18%), and malignant fibrous histiocytoma (11.45%).
Conclusion: As evidenced by the results of the present study, the ASIR of soft tissue sarcoma dramatically increased with age, and the peak ASIR occurred in the age range of above 65 years. The incidence rate of soft tissue sarcomas analyzed by disease site was higher in hip and lower limb than upper limb and pelvis region, and it was detected consistently in all age groups and both genders.
Keywords: Extremities; Sarcoma; Soft Tissue; Soft Tissue Neoplasm.
Figures
Similar articles
-
Incidence of primary bone sarcomas in Iranian population (2008-2015): A national population-based study.Caspian J Intern Med. 2022 Fall;13(4):741-748. doi: 10.22088/cjim.13.4.741. Caspian J Intern Med. 2022. PMID: 36420339 Free PMC article.
-
Bone and Soft Tissue Sarcoma Epidemiology in Iranian Elderly Population; an Analysis of the Iranian National Registry for Cancer (2009-2014 Years).Iran J Public Health. 2024 Jul;53(7):1670-1680. doi: 10.18502/ijph.v53i7.16061. Iran J Public Health. 2024. PMID: 39086408 Free PMC article.
-
Descriptive analysis of incidence, demographic characteristics, and survival outcomes of soft-tissue sarcoma of the extremities in Saudi Arabia.Sci Rep. 2024 Nov 25;14(1):29123. doi: 10.1038/s41598-024-79716-1. Sci Rep. 2024. PMID: 39581983 Free PMC article.
-
Overview of malignant soft-tissue sarcomas of the limbs.Clin Radiol. 2021 Dec;76(12):940.e1-940.e16. doi: 10.1016/j.crad.2021.08.011. Epub 2021 Oct 1. Clin Radiol. 2021. PMID: 34607656 Review.
-
Soft tissue sarcoma of the upper extremity.Hand Clin. 2004 Aug;20(3):325-33, vii. doi: 10.1016/j.hcl.2004.03.007. Hand Clin. 2004. PMID: 15275691 Review.
Cited by
-
Clinico-Demographic Profile Of Soft Tissue Sarcoma- 5 Year Experience From A Tertiary Care Centre Of Eastern India.Indian J Surg Oncol. 2024 Mar;15(Suppl 1):62-68. doi: 10.1007/s13193-023-01734-8. Epub 2023 Mar 16. Indian J Surg Oncol. 2024. PMID: 38545580 Free PMC article.
-
Magnetic Resonance Imaging Features for Distinguishing High-Grade From Low-Grade Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis.Cureus. 2024 Oct 31;16(10):e72784. doi: 10.7759/cureus.72784. eCollection 2024 Oct. Cureus. 2024. PMID: 39618573 Free PMC article. Review.
-
The economic and humanistic burden of tenosynovial giant cell tumor: a targeted literature review.Future Oncol. 2025 Aug;21(18):2385-2400. doi: 10.1080/14796694.2025.2520744. Epub 2025 Jun 22. Future Oncol. 2025. PMID: 40545745 Free PMC article. Review.
-
Two simple-to-use web-based nomograms to predict overall survival and cancer-specific survival in patients with extremity fibrosarcoma.Front Oncol. 2023 Feb 13;12:942542. doi: 10.3389/fonc.2022.942542. eCollection 2022. Front Oncol. 2023. PMID: 36861108 Free PMC article.
-
Progressive Improvement in 5-Year Survival Rates for Extremity Soft Tissue Sarcomas from 1999 to 2019.Sarcoma. 2024 Feb 19;2024:8880609. doi: 10.1155/2024/8880609. eCollection 2024. Sarcoma. 2024. PMID: 38410124 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials